These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 33283376)
1. Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience. Crown A; Carlson E; Rocha FG; Grumley JW Breast J; 2020 Dec; 26(12):2391-2394. PubMed ID: 33283376 [TBL] [Abstract][Full Text] [Related]
2. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast. Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR Breast J; 2016; 22(1):63-74. PubMed ID: 26534876 [TBL] [Abstract][Full Text] [Related]
3. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. Kraus-Tiefenbacher U; Bauer L; Scheda A; Schoeber C; Schaefer J; Steil V; Wenz F BMC Cancer; 2007 Sep; 7():178. PubMed ID: 17854511 [TBL] [Abstract][Full Text] [Related]
4. Survival benefit of breast-conserving surgery with adjuvant radiotherapy for young women with ductal carcinoma in situ: A population-based cohort study. Tang J; Wang J; Zhang D; Pan X Asian J Surg; 2023 Aug; 46(8):3173-3175. PubMed ID: 36898916 [No Abstract] [Full Text] [Related]
5. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125 [TBL] [Abstract][Full Text] [Related]
6. Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment. Kim JW; Cho Y; Choi J; Ahn SG; Jeong J; Lee IJ Ann Surg Oncol; 2019 Dec; 26(13):4294-4301. PubMed ID: 31520209 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma. Shah C; Vicini F Ann Surg Oncol; 2023 Oct; 30(11):6281-6283. PubMed ID: 37280311 [No Abstract] [Full Text] [Related]
8. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. Fisher ER CA Cancer J Clin; 1997; 47(1):52-64. PubMed ID: 8996078 [TBL] [Abstract][Full Text] [Related]
9. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer. Choi YJ; Shin YD; Song YJ World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132 [TBL] [Abstract][Full Text] [Related]
11. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast. Buchholz TA; Haffty BG; Harris JR J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862 [No Abstract] [Full Text] [Related]
12. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. Rakovitch E; Pignol JP; Hanna W; Narod S; Spayne J; Nofech-Mozes S; Chartier C; Paszat L J Clin Oncol; 2007 Dec; 25(35):5591-6. PubMed ID: 17984188 [TBL] [Abstract][Full Text] [Related]
13. Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center. Rosenberger LH; Mamtani A; Fuzesi S; Stempel M; Eaton A; Morrow M; Gemignani ML Ann Surg Oncol; 2016 Oct; 23(10):3239-46. PubMed ID: 27411549 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576 [TBL] [Abstract][Full Text] [Related]
15. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Subhedar P; Olcese C; Patil S; Morrow M; Van Zee KJ Ann Surg Oncol; 2015 Oct; 22(10):3273-81. PubMed ID: 26215193 [TBL] [Abstract][Full Text] [Related]
16. Initiation of an Intraoperative Radiotherapy Program at a Safety net Hospital: What Is the Impact of an Intraoperative Radiotherapy Program in Underserved Patients With Early Breast Cancer? Lalchandani P; Sila C; Ozao-Choy J; Dauphine C Am Surg; 2021 May; 87(5):833-838. PubMed ID: 33228433 [TBL] [Abstract][Full Text] [Related]
17. Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method? Roth AM; Kauer-Dorner D; Resch A; Schmid A; Thill M; Niehoff P; Melchert C; Berger D; Kovács G; Brachytherapy; 2014; 13(4):394-9. PubMed ID: 24946973 [TBL] [Abstract][Full Text] [Related]
18. Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up. ElSherif A; Freyvogel Ramirez M; Moore EC; Dietz JR; Tu C; Valente SA Am J Surg; 2023 Nov; 226(5):646-651. PubMed ID: 37481406 [TBL] [Abstract][Full Text] [Related]
19. Single institute experience of intraoperative radiation therapy in early-stage breast cancer. Chi MS; Ko HL; Chen CC; Hsu CH; Chen LK; Cheng FT Medicine (Baltimore); 2021 Nov; 100(46):e27842. PubMed ID: 34797318 [TBL] [Abstract][Full Text] [Related]
20. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence. Trombetta M; Hall M; Julian TB Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]